The front page of online version of The New York Times has a link to “From M.S. Patients, Outcry for Unproved Treatment“. It reports on Multiple Sclerosis and CCSVI (aka Chronic Cerebrospinal Venous Insufficiency) providing information about patients and doctors who are trying the “liberation procedure”. The most sobering sentence? “These critics warn that multiple […]
The title gives it away, but with which medical professional is a Multiple Sclerosis patient likely to have the most contact? In my experience, it has been her pharmacist. Most medications are refilled monthly. Between quarterly or annual visits to the neurologist, I believe most concerns about Multiple Sclerosis are related to medications. And in […]
If you’ve ever wondered how new Multiple Sclerosis drugs are developed, evaluated, and finally approved for the market, Bloomberg.com offers a link to the video of the FDA Committee Meeting on Novartis’s new Gilenia, the first pill for Multiple Sclerosis. After drug testing and before the FDA approves a new medication, a panel of health […]
Continue reading about Gilenia, MS Pill, Recommended for Approval by Panel